News
- Author:
- Jim Kling
Publish date: March 4, 2022
Open-label study confirms efficacy and COVID-19–related safety.
News
- Author:
- Jim Kling
Publish date: March 3, 2022
A prospective study found improved neutralizing antibody response with more time elapsed since therapy and vaccination.
News
- Author:
- Jim Kling
Publish date: March 3, 2022
Aspirin has been proven effective in reducing colon cancer recurrence rates, but this new randomized, controlled trial contradicts epidemiological ...
News
- Author:
- Jim Kling
Publish date: March 1, 2022
Avoidant/restrictive food intake disorder can be an issue, but it’s tough to distinguish from normal disease maintenance.
News
- Author:
- Jim Kling
Publish date: February 28, 2022
Proposed new criteria may help specialists, but they should also help primary care physicians be more confident in making a diagnosis.
News
- Author:
- Jim Kling
Publish date: February 23, 2022
Avoidant/restrictive food intake disorder can be an issue, but it’s tough to distinguish from normal disease maintenance.
News
- Author:
- Jim Kling
Publish date: February 17, 2022
Tumor-infiltrating lymphocytes show promise in six patients.
News
- Author:
- Jim Kling
Publish date: February 17, 2022
A SEER study confirms known risks, but also finds elevated rates of breast cancer.
News
- Author:
- Jim Kling
Publish date: February 11, 2022
States that expanded Medicaid saw higher rates of colon cancer diagnosis in Hispanics, but not Blacks
News
- Author:
- Jim Kling
Publish date: February 10, 2022
This research reveals details on the JAK inhibitor’s pharmacokinetics, including possible targets for future research.
News
- Author:
- Jim Kling
Publish date: February 4, 2022
Review and expert opinion outlines treatment options and highlights similarities to functional dyspepsia.
News
- Author:
- Jim Kling
Publish date: January 26, 2022
The AK104 antibody treatment combined with chemotherapy demonstrated a manageable safety profile.
News
- Author:
- Jim Kling
Publish date: January 25, 2022
A study of elderly patients with metastatic colon cancer shows no benefit and an increased neuropathy risk.
News
- Author:
- Jim Kling
Publish date: January 24, 2022
Allotments for this chemotherapy drug are waning but patients are willing to travel for treatment.
News
- Author:
- Jim Kling
Publish date: January 21, 2022
Metabolic-associated fatty liver disease may be another cluster phenotype of long COVID.
